- Home
- BNTX vs DXCM Comparison
BNTX vs DXCM Comparison
Compare BNTX & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNTX
- DXCM
- Stock Information
- Founded
- BNTX 2008
- DXCM 1999
- Country
- BNTX Germany
- DXCM United States
- Employees
- BNTX N/A
- DXCM N/A
- Industry
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- DXCM Medical/Dental Instruments
- Sector
- BNTX Health Care
- DXCM Health Care
- Exchange
- BNTX Nasdaq
- DXCM Nasdaq
- Market Cap
- BNTX 26.4B
- DXCM 34.1B
- IPO Year
- BNTX 2019
- DXCM 2005
- Fundamental
- Price
- BNTX $110.65
- DXCM $84.78
- Analyst Decision
- BNTX Strong Buy
- DXCM Strong Buy
- Analyst Count
- BNTX 18
- DXCM 20
- Target Price
- BNTX $141.60
- DXCM $98.85
- AVG Volume (30 Days)
- BNTX 627.8K
- DXCM 3.7M
- Earning Date
- BNTX 08-04-2025
- DXCM 07-30-2025
- Dividend Yield
- BNTX N/A
- DXCM N/A
- EPS Growth
- BNTX N/A
- DXCM N/A
- EPS
- BNTX N/A
- DXCM 1.33
- Revenue
- BNTX $2,968,331,171.00
- DXCM $4,148,000,000.00
- Revenue This Year
- BNTX N/A
- DXCM $16.74
- Revenue Next Year
- BNTX $8.61
- DXCM $15.42
- P/E Ratio
- BNTX N/A
- DXCM $63.85
- Revenue Growth
- BNTX 0.61
- DXCM 9.11
- 52 Week Low
- BNTX $76.53
- DXCM $57.52
- 52 Week High
- BNTX $131.49
- DXCM $117.19
- Technical
- Relative Strength Index (RSI)
- BNTX 57.02
- DXCM 52.53
- Support Level
- BNTX $105.35
- DXCM $82.96
- Resistance Level
- BNTX $114.00
- DXCM $85.92
- Average True Range (ATR)
- BNTX 2.56
- DXCM 2.11
- MACD
- BNTX 0.19
- DXCM -0.01
- Stochastic Oscillator
- BNTX 70.69
- DXCM 43.43
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.